Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$6.31M Buy
54,391
+38
+0.1% +$4.43K 0.07% 198
2021
Q1
$6.51M Buy
54,353
+611
+1% +$72.4K 0.08% 201
2020
Q4
$5.88M Buy
53,742
+934
+2% +$102K 0.07% 196
2020
Q3
$5.75M Sell
52,808
-6,304
-11% -$640K 0.08% 180
2020
Q2
$5.41M Sell
59,112
-9,097
-13% -$822K 0.08% 203
2020
Q1
$5.38M Sell
68,209
-378
-0.6% -$31.5K 0.09% 187
2019
Q4
$5.96M Buy
68,587
+2,297
+3% +$192K 0.06% 239
2019
Q3
$5.55M Sell
66,290
-1,320
-2% -$112K 0.06% 253
2019
Q2
$5.69M Sell
67,610
-6,046
-8% -$476K 0.06% 238
2019
Q1
$5.89M Sell
73,656
-1,650
-2% -$123K 0.06% 215
2018
Q4
$5.45M Buy
75,306
+977
+1% +$68.7K 0.07% 190
2018
Q3
$5.45M Sell
74,329
-4,041
-5% -$265K 0.05% 257
2018
Q2
$4.78M Sell
78,370
-5,663
-7% -$343K 0.05% 304
2018
Q1
$5.04M Sell
84,033
-1,008
-1% -$60.7K 0.05% 261
2017
Q4
$4.85M Buy
85,041
+498
+0.6% +$27.6K 0.05% 308
2017
Q3
$4.51M Sell
84,543
-55,155
-39% -$2.77M 0.04% 346
2017
Q2
$6.79M Buy
139,698
+5,823
+4% +$264K 0.06% 213
2017
Q1
$5.95M Sell
133,875
-27,288
-17% -$1.18M 0.05% 246
2016
Q4
$6.19M Sell
161,163
-1,900
-1% -$75.3K 0.05% 276
2016
Q3
$6.9M Sell
163,063
-3,128
-2% -$134K 0.05% 283
2016
Q2
$6.53M Sell
166,191
-3,299
-2% -$131K 0.06% 308
2016
Q1
$7.09M Buy
169,490
+1,937
+1% +$76.7K 0.07% 284
2015
Q4
$7.53M Buy
167,553
+1,083
+0.7% +$47.8K 0.07% 252
2015
Q3
$6.7M Sell
166,470
-2,929
-2% -$138K 0.07% 259
2015
Q2
$8.31M Buy
169,399
+32,049
+23% +$1.54M 0.1% 242
2015
Q1
$6.36M Sell
137,350
-800
-0.6% -$36.7K 0.07% 302
2014
Q4
$6.22M Buy
138,150
+101,218
+274% +$4.41M 0.07% 304
2014
Q3
$1.54M Sell
36,932
-5,300
-13% -$224K 0.04% 282
2014
Q2
$1.73M Buy
42,232
+12,368
+41% +$486K 0.05% 285
2014
Q1
$1.15M Sell
29,864
-16,500
-36% -$636K 0.03% 327
2013
Q4
$1.78M Sell
46,364
-13,300
-22% -$490K 0.07% 232
2013
Q3
$1.98M Sell
59,664
-150,936
-72% -$5.3M 0.09% 216
2013
Q2
$7.39M Buy
+210,600
New +$7.72M 0.26% 117

Other funds holding ABT

QS Investors's ABT Position: Q2 2021 in Review

QS Investors increased its Abbott (ABT) stake by 0.07% in Q2 2021, buying an estimated $4.43K and bringing the position to 54,391 shares worth $6.31M. The position accounts for 0.07% of the portfolio, ranked #198.

QS Investors first reported a position in ABT in Q2 2013 and has held it in 33 quarters since. The position peaked at $8.31M in Q2 2015. 2,503 funds tracked by Wall St. Rank hold ABT as of Q2 2021.

  • QS Investors held 54,391 shares of Abbott worth $6.31M as of Q2 2021.
  • QS Investors bought 38 Abbott shares in Q2 2021, an estimated $4.43K.
  • Abbott made up 0.07% of QS Investors's portfolio in Q2 2021, its #198 holding.
  • QS Investors first reported a position in Abbott in Q2 2013 and has held it in 33 quarters since.
  • QS Investors's Abbott position peaked at $8.31M in Q2 2015.
  • 2,503 funds tracked by Wall St. Rank held Abbott as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.